1 Min Read
Dec 11 (Reuters) - Boston Scientific Corp
* Says US FDA advisory committee votes 13-1 that benefits of Watchman anti-stroke device outweigh risks
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.